BioNTech
Pfizer, BioNTech ready flu-COVID combo vaccine for phase 3 trial
In an exciting race reminiscent of their previous encounters, Pfizer and BioNTech have once again taken on their recurring competitor, ...
Moderna, BioNTech face hurdles in cancer vaccine production after COVID success
Moderna and BioNTech, both navigating their post-COVID future while reimagining cancer treatments, have encountered manufacturing hurdles along their respective journeys. ...
BioNTech’s CAR-T/CARVac Combo Shows High Response Rates in Solid Tumors, But Also Higher Toxicity (ESMO 2023)
ESMO 2023: LBA35 BioNTech’s innovative manufacturing process for CAR-T therapy, BNT211, has shown promising results in treating solid tumors. While ...
Pfizer Collaborates with Ginkgo in a $331 Million Biobucks Partnership
Ginkgo Bioworks has secured a substantial partnership with pharmaceutical giant Pfizer, marking a significant milestone in its portfolio of collaborations. ...
CEPI funds BioNTech’s mRNA-based mpox vaccine trial with $90 million
BioNTech, the German biotech renowned for its groundbreaking mRNA COVID-19 vaccine, is embarking on clinical trials for an mRNA vaccine ...
BioNTech and DualityBio Advance Novel HER2-low Breast Cancer Drug to Phase III Trial
BioNTech, the renowned name behind the COVID-19 vaccine breakthrough, is venturing into uncharted territory with its licensed antibody-drug conjugate (ADC), ...
Pfizer and BioNTech Get Green Light for Omicron Vaccine in Europe by CHMP
Pfizer and BioNTech have unveiled their latest breakthrough in the post COVID era. Brace yourselves for the Omicron XBB.1.5-adapted monovalent ...
Pfizer and BioNTech challenge Moderna’s mRNA vaccine patents in a bid to end monopoly
The legal battle between Moderna and its rivals Pfizer and BioNTech over the patents related to mRNA vaccine production is ...
Legal Engagements Amid Scientific Advancements: Alnylam’s Ongoing Interplay with Moderna
In the intricate choreography of the biopharmaceutical world, where innovation and intellectual property intertwine, a dramatic legal ballet unfolds. Alnylam, ...
Twitter and BioNTech under fire for evading COVID-19 vaccine questions
The regulatory organization overseeing the German communications sector has accused BioNTech of attempting to evade a public discussion regarding vaccine ...
In its COVID-19 vaccination lawsuits against Pfizer and BioNTech, CureVac makes further claims under the patent statute
Source – CureVac CureVac is intensifying its patent battle over COVID-19 vaccines by asserting additional claims against Pfizer and BioNTech ...
Moderna Files Two New Patent Lawsuits Against mRNA Competitors Pfizer and BioNTech
In the ongoing patent disputes surrounding COVID-19 vaccines, Moderna has expanded its legal battle against Pfizer and BioNTech by filing ...
Comprehensive Guide to mRNA Vaccines: Advancements in COVID-19 Immunization
Introduction At our organization, we are dedicated to providing valuable information on the latest advancements in COVID-19 vaccines. In this ...
In Germany, a COVID-19 vaccine damage claim will be defended by BioNTech
Source- BioNTech The COVID-19 vaccine partner of Pfizer, BioNTech, is going to court in its native Germany to defend itself ...
